Understanding the Pathophysiology of Preeclampsia: Exploring the Role of Antiphospholipid Antibodies and Future Directions DOI Open Access
Melinda-Ildiko Mitranovici, Diana Maria Chiorean,

Raluca Moraru

и другие.

Journal of Clinical Medicine, Год журнала: 2024, Номер 13(9), С. 2668 - 2668

Опубликована: Май 2, 2024

Preeclampsia (PE) is a hypertensive disorder in pregnancy associated with significant fetal and maternal complications. Antiphospholipid syndrome (APS) an acquired form of thrombophilia characterized by recurrent venous or arterial thrombosis obstetric complications that significantly increases morbidity mortality rates. While preeclampsia may not be the most prevalent complication APS, it impacts long-term health both mother child. The treatment antiphospholipid different from as independent disease. Despite current treatments involving anticoagulants, antiplatelet agents, antihypertensive drugs, persist, underscoring need for cohesive management effective treatments. objective our review to briefly present knowledge about physiopathology role antibodies this process. Based on existing literature, aims identify future directions molecular pathology toward discovery biomarkers targeted application multidisciplinary approaches prognostic models, including new biomarkers, could beneficial prediction PE.

Язык: Английский

Bioactive Hydrogel Based on Collagen and Hyaluronic Acid Enriched with Freeze-Dried Sheep Placenta for Wound Healing Support DOI Open Access

Julia Sadlik,

Edyta Kosińska,

Dagmara Słota

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(3), С. 1687 - 1687

Опубликована: Янв. 30, 2024

In an increasingly aging society, there is a growing demand for the development of technology related to tissue regeneration. It involves appropriate biomaterials whose properties will allow desired biological response be obtained. Bioactivity strongly affected by proper selection active ingredients. The aim this study was produce bioactive hydrogel materials based on hyaluronic acid and collagen modified addition placenta. These were intended use as dressings, their physicochemical investigated under simulated environmental conditions. incubated in vitro different fluids simulating environment human body (e.g., fluid) then stored at temperature close temperature. Using FT-IR spectrophotometer, functional groups present composites identified. with added placenta showed increase swelling factor more than 300%. results obtained confirmed potential using material absorbent dressing. This indicated pH conductometric measurements, sorption, degradation, surface analysis optical microscope. evaluation cytosafety tested biomaterials. activate monocytes, which may indicate beneficial first phases wound healing. proved nontoxic has medical use.

Язык: Английский

Процитировано

5

Collateral Damage in the Placenta during Viral Infection in Pregnancy: A Possible Mechanism for Vertical Transmission and an Adverse Pregnancy Outcome DOI Creative Commons

Víctor Javier Cruz-Holguín,

Luis Didier González-García,

Manuel Adrían Velazquez-Cervantes

и другие.

Diseases, Год журнала: 2024, Номер 12(3), С. 59 - 59

Опубликована: Март 20, 2024

In mammals, the placenta is a connection between mother and new developing organism. This tissue has protective function against some microorganisms, transports nutrients, exchanges gases excretory substances fetus. Placental mainly composed of chorionic villi functional units called trophoblasts (cytotrophoblasts, syncytiotrophoblast, extravillous trophoblasts). However, viruses have developed mechanisms that help them invade placenta, causing various conditions such as necrosis, poor perfusion, membrane rupture which, in turn, can impact development fetus put mother’s health at risk. this study, we collected most relevant information about viral infection during pregnancy which affect both fetus, leading to an increase probability vertical transmission. Knowing these could be for research maternal–fetal context may provide options therapeutic targets biomarkers fetal prognosis.

Язык: Английский

Процитировано

5

Diagnosis, Prevention, and Management of Fetal Growth Restriction (FGR) DOI Open Access
Panagiotis Tsikouras, Panagiotis Antsaklis, Konstantinos Nikolettos

и другие.

Journal of Personalized Medicine, Год журнала: 2024, Номер 14(7), С. 698 - 698

Опубликована: Июнь 28, 2024

Fetal growth restriction (FGR), or intrauterine (IUGR), is still the second most common cause of perinatal mortality. The factors that contribute to fetal can be categorized into three distinct groups: placental, fetal, and maternal. prenatal application various diagnostic methods can, in many cases, detect deterioration condition time because nature above disorder thoroughly investigated by applying a combination biophysical biochemical methods, which determine state embryo-placenta unit assess possible increased risk failure outcome potential for later health problems. When considering therapeutic intervention, key question whether it utilized during pregnancy. Currently, there are no known treatment interventions effectively enhance placental function promote weight development. Nevertheless, cases with fetuses diagnosed restriction, immediate termination pregnancy may have advantages not only terms minimizing mortality but primarily reducing long-term morbidity childhood maturity.

Язык: Английский

Процитировано

5

Exploring characteristics of placental transcriptome and cord serum metabolome associated with low birth weight in Kele pigs DOI

Caizai Zhang,

Zhimin Wu,

Guangling Hu

и другие.

Tropical Animal Health and Production, Год журнала: 2023, Номер 55(5)

Опубликована: Сен. 28, 2023

Язык: Английский

Процитировано

10

Understanding the Pathophysiology of Preeclampsia: Exploring the Role of Antiphospholipid Antibodies and Future Directions DOI Open Access
Melinda-Ildiko Mitranovici, Diana Maria Chiorean,

Raluca Moraru

и другие.

Journal of Clinical Medicine, Год журнала: 2024, Номер 13(9), С. 2668 - 2668

Опубликована: Май 2, 2024

Preeclampsia (PE) is a hypertensive disorder in pregnancy associated with significant fetal and maternal complications. Antiphospholipid syndrome (APS) an acquired form of thrombophilia characterized by recurrent venous or arterial thrombosis obstetric complications that significantly increases morbidity mortality rates. While preeclampsia may not be the most prevalent complication APS, it impacts long-term health both mother child. The treatment antiphospholipid different from as independent disease. Despite current treatments involving anticoagulants, antiplatelet agents, antihypertensive drugs, persist, underscoring need for cohesive management effective treatments. objective our review to briefly present knowledge about physiopathology role antibodies this process. Based on existing literature, aims identify future directions molecular pathology toward discovery biomarkers targeted application multidisciplinary approaches prognostic models, including new biomarkers, could beneficial prediction PE.

Язык: Английский

Процитировано

4